PHARMACEUTICAL COMPOSITION COMBINING LAMOTRIGINE AND CLONAZEPAM, AND USE THEREOF FOR TREATING CONVULSIVE DISORDERS AND EPILEPTIC SYNDROMES

摘要

The invention relates to a pharmaceutical composition consisting of the synergistic combination of an anticonvulsant agent such as the active ingredient Lamotrigine and a benzodiazepine agent such as the active ingredient clonazepam, said active ingredients being formulated in a single dosage unit to be orally administered in the form of capsules or tablets. Said composition can be used for the control and treatment of illnesses such as convulsive disorders, epileptic syndromes and other related illnesses.